Gelesis Holdings Price to Sales Ratio 2021-2022 | GLS
Historical PS ratio values for Gelesis Holdings (GLS) over the last 10 years. The current P/S ratio for Gelesis Holdings as of February 03, 2023 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Gelesis Holdings P/S Ratio Historical Data |
| Date |
Stock Price |
TTM Sales per Share |
Price to Sales Ratio |
| 2023-02-03 |
0.33 |
|
0.97 |
| 2022-09-30 |
1.08 |
$0.34 |
3.22 |
| 2022-06-30 |
1.55 |
$0.78 |
1.99 |
| 2022-03-31 |
4.53 |
$1.05 |
4.33 |
| 2021-12-31 |
9.96 |
$1.48 |
6.72 |
| 2021-09-30 |
9.92 |
$1.48 |
6.70 |
| 2021-06-30 |
9.79 |
$0.94 |
10.37 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.024B |
$0.011B |
|
Gelesis is a consumer-centered biotherapeutics company advancing a novel category of treatments for weight management and gut related chronic diseases. Gelesis, formerly known as Capstar Special Purpose Acquisition Corp., is based in BOSTON.
|
